What Is The Predicted Revenue Outlook For The Global Post-Operative Nausea And Vomiting Market To Surpass $2.94 Billion?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
What Is The Projected Valuation Of The Post-Operative Nausea And Vomiting Market In The Coming Years?
The market for post-operative nausea and vomiting has experienced significant expansion in past years. It is projected to rise from a value of $2.11 billion in 2024 to $2.25 billion in 2025, with a compound annual growth rate (CAGR) of 6.8%. Factors contributing to the growth recorded in the historical period include increased research and development initiatives, a growing need for innovative therapies, a surge in healthcare spending, a heightened emphasis on personalized medicine, and a rising uptake of digital health technologies.
It is anticipated that the market size for post-operative nausea and vomiting will experience substantial growth in the coming years, reaching a value of $2.94 billion in 2029, with a Compound Annual Growth Rate (CAGR) of 6.9%. This upward projection during the forecast period is linked to the increasing demand for pharmaceuticals, growth in combination therapy, heightened consciousness and investment in healthcare, expansion of the elderly population, and a surge in cancer cases. Prominent trends projected for the forecast period include enhanced antiemetic therapies, strategic partnerships, innovative drug development, the incorporation of sophisticated diagnostic tools, and the use of electronic simulation devices.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=22109&type=smp
Which Market Dynamics Are Playing A Critical Role In The Growth Of The Post-Operative Nausea And Vomiting Market?
The surge in the number of surgical procedures is anticipated to accelerate the expansion of the post-operative nausea and vomiting market in the future. These procedures, which involve employing medical instruments to diagnose, treat, or extract damaged tissues, organs, or anomalies through surgical manipulation or incision, are seeing an upward trend. This rise is attributable to medical technology advancements, making surgeries safer, more efficient, and minimally invasive, leading to patient acceptance and broader usage. The management of post-operative nausea and vomiting enhances surgical procedures by improving patient comfort, shortening recovery time, minimizing complication risks, facilitating better post-operative care, and ultimately boosting overall surgical results. For example, data from the Australian Institute of Health and Welfare, a government agency based in Australia, in November 2024 revealed that during the 2023-24 period, the number of patients admitted for surgery from public hospital elective surgery waiting lists stood at 771,600, marking a 4.9% increase in comparison to the 2022–23 period. Consequently, the increasing number of surgical procedures is stimulating the development of the post-operative nausea and vomiting market.
Which Sub-Segments Are Driving Growth Within The Post-Operative Nausea And Vomiting Market?
The post-operative nausea and vomitingmarket covered in this report is segmented –
1) By Treatment Type: Serotonin Antagonists; Steroids; Dopamine Antagonists; Neurokinin NK-1 Receptor Antagonists; Non-pharmacological Treatment; Other Treatment Types
2) By Route Of Administration: Oral; Intravenous; Transdermal; Other Route Of Administrations
3) By Patient Demographics: Pediatric Patients; Adult Patients; Geriatric Patients
4) By Surgical Procedure Type: Orthopedic Surgery; Gynecological Surgery; General Surgery; Cardiac Surgery; Ophthalmic Surgery
5) By End-User: Hospitals; Ambulatory Surgical Centers; Specialty Clinics; Other End-Users
Subsegments:
1) By Serotonin Antagonists Type: Ondansetron; Granisetron; Palonosetron; Dolasetron; Tropisetron
2) By Steroids Type: Dexamethasone; Methylprednisolone; Hydrocortisone; Prednisolone; Betamethasone
3) By Dopamine Antagonists Type: Metoclopramide; Droperidol; Prochlorperazine; Domperidone; Chlorpromazine
4) By Neurokinin NK-1 Receptor Antagonists Type: Aprepitant; Fosaprepitant; Rolapitant; Netupitant; Casopitant
5) By Non-Pharmacological Treatment Type: Acupressure; Aromatherapy; Hypnotherapy; Electroacupuncture; Ginger Supplements
6) By Other Treatment Types: Antihistamines; Anticholinergics; Cannabinoids; Combination Therapy; Herbal & Natural Remedies
What Key Trends Are Driving Growth In The Post-Operative Nausea And Vomiting Market?
Key players in the post-operative nausea and vomiting market are developing injectable medications with advanced emulsions and sustained-release technologies to enhance effectiveness and provide longer symptom relief for surgical patients. For instance, in July 2024, Avenacy, a US specialty pharma company, launched Palonosetron Hydrochloride Injection in single-dose vials to reduce dosing errors and enhance patient safety. This injection is used to prevent chemotherapy-induced nausea and vomiting as well as post-operative nausea and vomiting, providing up to 24 hours of symptom control.
Which Players Are Shaping The Competitive Landscape Of The Post-Operative Nausea And Vomiting Market?
Major companies operating in the post-operative nausea and vomiting market are Pfizer Inc., Merck KGaA, Novartis AG, GlaxoSmithKline Plc, Takeda Pharmaceutical Company Limited. , Baxter Corporation, Teva Pharmaceutical Industries Ltd., Sandoz Group AG, Daiichi Sankyo Inc., Fresenius Kabi AG, Eisai Co. Ltd., Dr. Reddy’s Laboratories, Kyowa Hakko Kirin Taiwan Co. Ltd., Cipla Ltd., Alkem Laboratories Ltd., Eagle Pharmaceuticals Inc. , Camurus AB, Helsinn Healthcare SA, Heron Therapeutics Inc., Advacare Pharma
Access The Complete Report Here:
How Do Regional Dynamics Influence The Post-Operative Nausea And Vomiting Market Performance?
North America was the largest region in the post-operative nausea and vomiting market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the post-operative nausea and vomiting market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=22109&type=smp
Browse Through More Reports Similar to the Global Post-Operative Nausea And Vomiting Market 2025, By The Business Research Company
Antiemetics And Antinauseants Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/antiemetics-and-antinauseants-global-market-report
Chemotherapy Induced Nausea And Vomiting Cinv Global Market Report 2025
Chemotherapy Induced Nausea And Vomiting Cinv Global Market Report 2025
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
